Lyra Therapeutics, INC. (LYRA) — DEFA14A Filings
All DEFA14A filings from Lyra Therapeutics, INC.. Browse 1 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (1)
-
Lyra Therapeutics Files Proxy Materials
— May 9, 2025 Risk: low
Lyra Therapeutics, Inc. filed a Definitive Additional Materials proxy statement on May 9, 2025. This filing relates to the company's proxy materials, which are
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX